American Chemical Society
jm1c00777_si_004.csv (5.42 kB)

Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human Cyclophilin A to Inhibit Apoptosis Inducing Factor-Mediated Cell Death

Download (5.42 kB)
posted on 2021-08-02, 15:07 authored by Luigi Russo, Fabiola Mascanzoni, Biancamaria Farina, Amalia Mihaela Dolga, Alessandra Monti, Andrea Caporale, Carsten Culmsee, Roberto Fattorusso, Menotti Ruvo, Nunzianna Doti
Blocking the interaction between the apoptosis-inducing factor (AIF) and cyclophilin A (CypA) by the AIF fragment AIF(370–394) is protective against glutamate-induced neuronal cell death and brain injury in mice. Starting from AIF(370–394), we report the generation of the disulfide-bridged and shorter variant AIF(381–389) and its structural characterization by nuclear magnetic resonance (NMR) in the free and CypA-bound state. AIF(381–389) in both the free and bound states assumes a β-hairpin conformation similar to that of the fragment in the AIF protein and shows a highly reduced conformational flexibility. This peptide displays a similar in vitro affinity for CypA, an improved antiapoptotic activity in cells and an enhanced proteolytic stability compared to the parent peptide. The NMR-based 3D model of the AIF(381–389)/CypA complex provides a better understanding of the binding hot spots on both the peptide and the protein and can be exploited to design AIF/CypA inhibitors with improved pharmacokinetic and pharmacodynamics features.